Ye et al. BMC Cancer 2010, 10:611 http://www.biomedcentral.com/1471-2407/10/611 B1 is downregulated in renal cell carcinomas and modulates cell growth. Transl Res 2008, 151(3):134-140. 29. Wong OG, Nitkunan T, Oinuma I, Zhou C, Blanc V, Brown RS, Bott SR, Nariculam J, Box G, Munson P, et al: Plexin-B1 mutations in prostate cancer. Proc Natl Acad Sci USA 2007, 104(48):19040-19045. 30. Valente G, Nicotra G, Arrondini M, Castino R, Capparuccia L, Prat M, Kerim S, Tamagnone L, Isidoro C: Co-expression of plexin-B1 and Met in human breast and ovary tumours enhances the risk of progression. Cell Oncol 2009, 31(6):423-436. 31. Tavassoli FADP, editors: World Health Organization Classification of Tumours. Tumours of the Breast and Female Genital Organs. Lyon: IARC Press; 2003, 113-145. 32. Sobin LHWC, editors: International Union Against Cancer (UICC). TNM Classification of Malignant Tumours. New York: Wiley-Liss;, 6 2002, 165-169. 33. Gatalica Z, Lele SM, Rampy BA, Norris BA: The expression of Fhit protein is related inversely to disease progression in patients with breast carcinoma. Cancer 2000, 88(6):1378-1383. 34. Ye JCW SM, Wu MF, Zhou L, You LY, Chen Y, Xu G, Lu YP, Wang SX: Expression of plexin-B1 in Human Breast Cancer and Its Relationship with Tumor Lymphatic Metastasis. CANCER RESEARCH ON PREVENTION AND TREATMENT 2007, , 11: 37-40+84. 35. Kumar S, Bryant CS, Chamala S, Qazi A, Seward S, Pal J, Steffes CP, Weaver DW, Morris R, Malone JM, et al: Ritonavir blocks AKT signaling, activates apoptosis and inhibits migration and invasion in ovarian cancer cells. Mol Cancer 2009, 8(26). 36. Chen CH, Lai JM, Chou TY, Chen CY, Su LJ, Lee YC, Cheng TS, Hong YR, Chou CK, Whang-Peng J, et al: VEGFA upregulates FLJ10540 and modulates migration and invasion of lung cancer via PI3K/AKT pathway. PLoS One 2009, 4(4):e5052. 37. Basile JR, Castilho RM, Williams VP, Gutkind JS: Semaphorin 4D provides a link between axon guidance processes and tumor-induced angiogenesis. Proc Natl Acad Sci USA 2006, 103(24):9017-9022. 38. Giordano S, Corso S, Conrotto P, Artigiani S, Gilestro G, Barberis D, Tamagnone L, Comoglio PM: The semaphorin 4D receptor controls invasive growth by coupling with Met. Nat Cell Biol 2002, 4(9):720-724. 39. Zagzag D, Esencay M, Mendez O, Yee H, Smirnova I, Huang Y, Chiriboga L, Lukyanov E, Liu M, Newcomb EW: Hypoxia- and vascular endothelial growth factor-induced stromal cell-derived factor-1alpha/CXCR4 expression in glioblastomas: one plausible explanation of Scherer’s structures. Am J Pathol 2008, 173(2):545-560. 40. Conrotto P, Valdembri D, Corso S, Serini G, Tamagnone L, Comoglio PM, Bussolino F, Giordano S: Sema4D induces angiogenesis through Met recruitment by Plexin B1. Blood 2005, 105(11):4321-4329. 41. Basile JR, Afkhami T, Gutkind JS: Semaphorin 4D/plexin-B1 induces endothelial cell migration through the activation of PYK2, Src, and the phosphatidylinositol 3-kinase-Akt pathway. Mol Cell Biol 2005, 25(16):6889-6898. 42. Herter S, Piper DE, Aaron W, Gabriele T, Cutler G, Cao P, Bhatt AS, Choe Y, Craik CS, Walker N, et al: Hepatocyte growth factor is a preferred in vitro substrate for human hepsin, a membrane-anchored serine protease implicated in prostate and ovarian cancers. Biochem J 2005, 390(Pt 1):125-136. 43. Mimura K, Kono K, Takahashi A, Kawaguchi Y, Mizukami Y, Fujii H: Vascular endothelial growth factor partially inhibits the trastuzumab-mediated antibody-dependent cellular cytotoxicity of human monocytes. Oncology 2007, 72(3-4):172-180. 44. Ito Y, Oinuma I, Katoh H, Kaibuchi K, Negishi M: Sema4D/plexin-B1 activates GSK-3beta through R-Ras GAP activity, inducing growth cone collapse. EMBO Rep 2006, 7(7):704-709. 45. Yadav S, Puri S, Linstedt AD: A primary role for Golgi positioning in directed secretion, cell polarity, and wound healing. Mol Biol Cell 2009, 20(6):1728-1736, Epub 2009 Jan 1721. 46. Steinmetz R, Wagoner HA, Zeng P, Hammond JR, Hannon TS, Meyers JL, Pescovitz OH: Mechanisms regulating the constitutive activation of the extracellular signal-regulated kinase (ERK) signaling pathway in ovarian cancer and the effect of ribonucleic acid interference for ERK1/2 on cancer cell proliferation. Mol Endocrinol 2004, 18(10):2570-2582. 47. Lee S, Helfman DM: Cytoplasmic p21Cip1 is involved in Ras-induced inhibition of the ROCK/LIMK/cofilin pathway. J Biol Chem 2004, 279(3):1885-1891. Page 11 of 11 48. Aurandt J, Li W, Guan KL: Semaphorin 4D activates the MAPK pathway downstream of plexin-B1. Biochem J 2006, 394:459-464. Pre-publication history The pre-publication history for this paper can be accessed here: http://www.biomedcentral.com/1471-2407/10/611/prepub doi:10.1186/1471-2407-10-611 Cite this article as: Ye et al.: Plexin-B1 silencing inhibits ovarian cancer cell migration and invasion. BMC Cancer 2010 10:611. Submit your next manuscript to BioMed Central and take full advantage of: • Convenient online submission • Thorough peer review • No space constraints or color ﬁgure charges • Immediate publication on acceptance • Inclusion in PubMed, CAS, Scopus and Google Scholar • Research which is freely available for redistribution Submit your manuscript at www.biomedcentral.com/submit